Improvement of chemotherapy efficacy by inactivation of a DNA-repair pathway
Data up to Jan 2025
Total Citations Per Year
Abstract
References (58)
Cancer: Principles and Practice of Oncology.
1991 • 8,402 citations
Inactivation of the DNA-Repair GeneMGMTand the Clinical Response of Gliomas to Alkylating Agents
2000 • 2,127 citations
Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is a common event in primary human neoplasia.
1999 • 1,252 citations
Mammalian O6-alkylguanine-DNA alkyltransferase: regulation and importance in response to alkylating carcinogenic and therapeutic agents.
1990 • 736 citations
Oxidative demethylation by Escherichia coli AlkB directly reverts DNA base damage
2002 • 723 citations
Clinical Relevance of MGMT in the Treatment of Cancer
2002 • 415 citations
DNA mismatch repair and O6-alkylguanine-DNA alkyltransferase analysis and response to Temodal in newly diagnosed malignant glioma.
1998 • 413 citations
Experimental evaluation of potential anticancer agents VIII. Effects of certain nitrosoureas on intracerebral L1210 leukemia.
1963 • 369 citations
Correlation of tumor O6 methylguanine-DNA methyltransferase levels with survival of malignant astrocytoma patients treated with bis-chloroethylnitrosourea: a Southwest Oncology Group study.
1998 • 300 citations
Retrospective study of the correlation between the DNA repair protein alkyltransferase and survival of brain tumor patients treated with carmustine.
1996 • 245 citations
Formation of the cross-link 1-[N3-deoxycytidyl),2-[N1-deoxyguanosinyl]ethane in DNA treated with N,N'-bis(2-chloroethyl)-N-nitrosourea.
1982 • 227 citations
Phase I trial of O6-benzylguanine for patients undergoing surgery for malignant glioma.
1998 • 214 citations
Phase II Trial of Carmustine Plus O6-Benzylguanine for Patients With Nitrosourea-Resistant Recurrent or Progressive Malignant Glioma
2002 • 191 citations
Sensitivity of human cell strains having different abilities to repair O6-methylguanine in DNA to inactivation by alkylating agents including chloroethylnitrosoureas.
1984 • 127 citations
O6-benzylguanine: a clinical trial establishing the biochemical modulatory dose in tumor tissue for alkyltransferase-directed DNA repair.
1999 • 127 citations
The delivery of BCNU to brain tumors
1999 • 116 citations
O6-methylguanine-DNA methyltransferase in human normal and tumor tissue from brain, lung, and ovary.
1991 • 115 citations
Phase I Trial of Carmustine Plus O6-Benzylguanine for Patients With Recurrent or Progressive Malignant Glioma
2000 • 112 citations
Phase I clinical and pharmacological study of O6-benzylguanine followed by carmustine in patients with advanced cancer.
2000 • 106 citations
Enhancement of Nitrosourea Activity in Medulloblastoma and Glioblastoma Multiforme
1992 • 102 citations
O6-Methylguanine-DNA methyltransferase in pretreatment tumour biopsies as a predictor of response to temozolomide in melanoma
1998 • 88 citations
Inactivation of O6-methylguanine-DNA methyltransferase and sensitization of human tumor cells to killing by chloroethylnitrosourea by O6-methylguanine as a free base.
1986 • 86 citations
O6-Methylguanine-DNA methyltransferase activity in human liver tumors
1991 • 86 citations
O6-benzylguanine enhances the sensitivity of a glioma xenograft with low O6-alkylguanine-DNA alkyltransferase activity to temozolomide and BCNU
1996 • 83 citations
O6-alkylguanine-DNA alkyltransferase depletion and regeneration in human peripheral lymphocytes following dacarbazine and fotemustine.
1991 • 73 citations
Synergistic efficacy of O6benzylguanine and 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) in a human colon cancer xenograft completely resistant to BCNU alone
1993 • 72 citations
Understanding and manipulating O6-methylguanine-DNA methyltransferase expression
1997 • 71 citations
Reduction of O6-alkylguanine-DNA alkyltransferase activity in HeLa cells treated with O6-alkylguanines.
1985 • 69 citations
O6-methylguanine formation, repair protein depletion and clinical outcome with a 4 hr schedule of temozolomide in the treatment of advanced melanoma: Results of a phase II study
2000 • 69 citations
Transfer of the E. coli O6-methyltransferase gene into repair-deficient human cells and restoration of cellular resistance to N-methyl-N′-nitro-N-nitrosoguanidine
1986 • 67 citations
Mismatch repair and differential sensitivity of mouse and human cells to methylating agents
1999 • 64 citations
Effect of O6-benzylguanine on the sensitivity of human colon tumor xenografts to 1,3-BIS(2-chloroethyl)-1-nitrosourea(BCNU)
1993 • 58 citations
Biological Consequences of Reactions with DNA: Role of Specific Lesions
1990 • 58 citations
Activity of O6-methylguanine-DNA methyltransferase in relation to p53 status and therapeutic response in ovarian cancer
1999 • 57 citations
Modulation of cyclophosphamide activity by O ? 6 -alkylguanine-DNA alkyltransferase
1999 • 57 citations
Chemosensitivity to triazene compounds and O6-alkylguanine-DNA alkyltransferase levels: Studies with blasts of leukaemic patients
1995 • 53 citations
O6-benzylguanine increases the sensitivity of human primary bone marrow cells to the cytotoxic effects of temozolomide.
1995 • 47 citations
O6-methylguanine-DNA methyltransferase activity and sensitivity to cyclophosphamide and cisplatin in human lung tumor xenografts
1998 • 46 citations
Phase I Study of Streptozocin- and Carmustine-Sequenced Administration in Patients With Advanced Cancer
1992 • 46 citations
Sequential administration of temozolomide and fotemustine: Depletion of O6-alkyl guanine-DNA transferase in blood lymphocytes and in tumours
1999 • 45 citations
Intracellular localization of human DNA repair enzyme methylguanine-DNA methyltransferase by antibodies and its importance.
1992 • 40 citations
Sequential administration of varying doses of dacarbazine and fotemustine in advanced malignant melanoma
1993 • 40 citations
O6-Methylguanine-DNA methyltransferase activity in human tumors
1992 • 39 citations
Monosaccharide-Linked Inhibitors of O6-Methylguanine-DNA Methyltransferase (MGMT): Synthesis, Molecular Modeling, and Structure−Activity Relationships
2001 • 39 citations
Relationship between O6-methylguanine-DNA methyltransferase levels and clinical response induced by chloroethylnitrosourea therapy in glioma patients.
1999 • 38 citations
Differential inactivation of mammalian and Escherichia coli O6-alkylguanine-DNA alkyltransferases by O6-benzylguanine
1994 • 37 citations
Carmustine and streptozocin in refractory melanoma: an attempt at modulation of O-alkylguanine-DNA-alkyltransferase.
1996 • 34 citations
Expression of the E. coli O6-methylguanine-methylphosphotriester methyltransferase gene in mammalian cells
1986 • 31 citations
O6‐Methylguanine‐DNA Methyltransferase (MGMT) as a Determinant of Resistance to Camptothecin Derivatives
2002 • 29 citations
Modulation of O6-alkylguanine-DNA alkyltransferase-mediated carmustine resistance using streptozotocin: a phase I trial.
1992 • 26 citations
Hypersensitivity of human tumor xenografts lacking O6-alkylguanine-DNA alkyltransferase to the anti-tumor agent 1-(4-amino-2-methyl-5-pyrimidinyl)methyl-3-(2-chloroethyl)-3-nitrosourea
1989 • 25 citations
Genetic Chemoprotection with Mutant O6-Alkylguanine-DNA-Alkyltransferases
2002 • 25 citations
Changes in O6-methylguanine-DNA methyltransferase expression during immortalization of cloned human fibroblasts
1996 • 24 citations
Inter- and intracellular heterogeneity of O6-alkylguanine-DNA alkyltransferase expression in human brain tumours: possible significance in nitrosourea therapy
1996 • 23 citations
O6-Methylguanine-DNA Methyltransferase in Ovarian Malignancy and Its Correlation with Postoperative Response to Chemotherapy
1994 • 19 citations
Expression of the O6-alkylguanine-DNA alkyltransferase gene is elevated in human breast tumor cells.
1998 • 15 citations
Immunohistochemical analysis of DNA mismatch repair protein and O6-methylguanine-DNA methyltransferase in melanoma metastases in relation to clinical response to DTIC-based chemotherapy
2002 • 14 citations
Deleted Work
1955 • 0 citations